RGD Peptide–Albumin Conjugate for Endothelization of Electrospun Materials


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

To improve the endothelization of 3D matrices produced by electrospinning we propose adding cyclo(RGDfC) peptide conjugated to human serum albumin (HSA) (HSA-c(RGDfC)) to the electrospinning solution. HSA-c(RGDfC) has been prepared using a bifunctional linker with N-hydroxysuccinimide and maleimide groups, and the product has been confirmed by 1Н NMR spectroscopy. Electrospun matrices have been fabricated from the solutions of 3% polyurethane Tecoflex EG-80A with 10% HSA and 0.01–1.3% HSA–c(RGDfC) (relative to Tec) in 1,1,1,3,3,3-hexafluoro-2-propanol. The presence of HSA and the cyclo(RGDfC) peptide on the surface of electrospun matrices has been confirmed by FTIR spectroscopy. The structure of matrices has been examined by scanning electron microscopy. The ability of the matrices to facilitate the adhesion of primary human umbilical vein endotheliocytes (HUVECs) has been studied. The presence of HSA–c(RGDfC) conjugate in the matrices enhanced cellular adhesion in a dose dependent manner with a maximum effect at 1% HSA-c(RGDfC).

About the authors

A. V. Cherepanova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Author for correspondence.
Email: a_cher@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630055

D. Akisheva

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences

Email: a_cher@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090

T. V. Popova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Novosibirsk State University

Email: a_cher@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090

B. P. Chelobanov

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Novosibirsk State University

Email: a_cher@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090

Yu. A. Chesalov

Boreskov Institute of Catalysis, Federal Research Center, Siberian Branch, Russian Academy of Sciences

Email: a_cher@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090

T. S. Godovikova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Novosibirsk State University

Email: a_cher@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090

A. A. Karpenko

Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Email: a_cher@niboch.nsc.ru
Russian Federation, Novosibirsk, 630055

P. P. Laktionov

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Email: a_cher@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630055


Copyright (c) 2019 Pleiades Publishing, Ltd.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies